Detail Information
Publications
From glutamatergic dysfunction to cognitive impairment: boundaries in the therapeutic of the schizophreniaP A Gaspar
Clínica Psiquiátrica Universitaria, Hospital Clinico de la Universidad de Chile, Santiago, Chile
Curr Pharm Biotechnol 13:1543-8. 2012..Also, we emphasize the role of certain chemical families as potential sources of new lead compounds with affinity for metabotropic glutamate receptors (mGluRs) with cognitive enhancing properties...
Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implicationsPablo A Gaspar
Clínica Psiquiátrica Universitaria, Hospital Clinico de la Universidad de Chile, Casilla, Santiago, Chile
J Neurochem 111:891-900. 2009..Therefore, in our view metabotropic glutamate receptors constitute a highly promising target for future drug treatment in this disease...
P300 amplitude is insensitive to working memory load in schizophreniaPablo A Gaspar
Clínica Psiquiátrica Universitaria, Hospital Clinico de la Universidad de Chile, Santiago, Chile
BMC Psychiatry 11:29. 2011..The aim of this study was to determine the dependency of the P300 component on WM load in a sample of SZ subjects...
